Viewing Study NCT05234905

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-02-03 @ 7:08 AM
Study NCT ID: NCT05234905
Status: UNKNOWN
Last Update Posted: 2022-02-10
First Post: 2022-01-27
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: H101 Combined With Camrelizumab for Recurrent Cervical Cancer
Sponsor: Zhejiang Cancer Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Uterine Cervical Neoplasms View
None Oncolytic Virotherapy View
None Camrelizumab View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Recurrent cervical cancer View
None H101 View
None Camrelizumab View
None Objective response rate View